Procedure for relapsed/refractory sickness should be made a decision based upon prior therapy and also The rationale why the initial treatment method was no more proper (e.g., refractoriness vs. intolerance). Ibrutinib is the current gold regular therapy for patients with relapsed/refractory ailment, determined by the final results of numerous phas